---

NeuroPI: Dementia

Each NeuroPI module is prepared by distinguished faculty who are acknowledged leaders in their respective fields. Each module is composed of a set of multiple-choice items with preferred responses, instructions on how to collect cases to assess one's practice, and resources for creating and implementing an improvement program. Participants are able to compare their performance pre- and post-intervention to assess what changes have occurred in their practice.

Pricing

Members: $199.00
Nonmembers: $699.00

Learning Objectives

As a result of this program the learner will:

1. Assess performance via chart audit comparing current performance with measures and best practices in order to select improvements to make.
2. Consult educational resources related to the measure(s) selected for improvement, design an intervention, and implement an improvement plan.
3. Re-evaluate performance via chart audit comparing current practice with measures and best practices to determine whether an improvement has been achieved as a result of the intervention.
4. Summarize practice, process and/or outcome changes resulting from the activity.

Featured Measures

• Staging of Dementia.
• Cognitive Assessment.
• Functional Status Assessment.
• Neuropsychiatric Symptom Assessment.
• Management of Neuropsychiatric Symptoms.
• Screening for Depressive Symptoms.
• Counseling Regarding Safety Concerns.
• Counseling Regarding Risks of Driving.
• Palliative Care Counseling and Advanced Care Planning.
• Caregiver Education and Support.

The quality measures in this NeuroPI program are (c) 2011 American Medical Association. All Rights Reserved.

Change Intended

As a result of this program, the participant will determine individual practice gaps and address them through a performance improvement plan designed to improve competence, performance, and patient outcomes.

Core Competencies

• Interpersonal Skills and Communication
• Medical Knowledge
• Patient Care
• Practice-based Learning and Improvement
• Professionalism

Date of Release

July 12, 2012

This module is eligible for CME credits for three years from the release date.

Confidentiality of Data

Faculty

DAVID KNOPMAN, MD, FAAN
Professor of Neurology
Mayo Clinic, Rochester, MN
*Dr. Knopman has received personal compensation for activities with Lilly Pharmaceuticals as a data safety monitoring board member. Dr. Knopman has received personal compensation in an editorial capacity for Neurology.

GREGORY JICHA, MD
Associate Professor of Neurology
University of Kentucky College of Medicine, Lexington, KY
*Dr. Jicha has received personal compensation for activities with Lilly Pharmaceuticals as a scientific advisory board member. Dr. Jicha has received contract research support from Jannsen, Baxter and Medivation.

BRIAN OTT, MD, FAAN
Professor of Neurology Alpert Medical School of Brown University, Providence, RI
*Dr. Ott has received research grant support rom Univita, Pfizer/Jannsen, Baxter, and Ely Lilly/Avid.

NeuroPI Editor:

DONALD J. IVERSON, MD, FAAN
Humboldt Neurological Medical Group, Eureka, California
*Dr. Iverson has nothing to disclose.

PIP Taskforce:

RALPH F. JOZEFOWICZ, MD, FAAN
AAN Board Member
University of Rochester, Rochester, New York
*Dr. Jozefowicz has received personal compensation in an editorial capacity for The Neurologist.

CYNTHIA L. COMELLA, MD, FAAN
Education Committee Chair
Rush University Medical Center, Chicago, Illinois
*Dr. Comella has received personal compensation for activities with Ipsen, Merz Pharma, Allergan, Inc., UCB Pharma, and Eisai Inc., as a consultant. Dr. Comella's institution has received research support from Merz Pharma, Allergan, Inc., Ipsen, and Boehringer Ingelheim Pharmaceuticals, Inc.

JONATHAN P. HOSEY, MD, FAAN
Practice Committee Chair
Geisinger Medical Center, Danville, Pennsylvania
*Dr. Hosey has nothing to disclose.

NeuroPI Staff:

Minneapolis, Minnesota

Tracy King, MA, Senior Manager, Education
*Ms. King has nothing to disclose.

Lucy Persaud Samaroo, Program Manager, Education
*Ms. Persaud Samaroo has nothing to disclose.

Rebecca J. Swain-Eng, MS, Senior Manager, Measurement and Implementation
*Ms. Swain-Eng has nothing to disclose.

Susan Rodmyre, Director, Education
*Ms. Rodmyre has nothing to disclose.

Lori Strachota, Program Manager, Conference Management, Registration
*Ms. Strachota has nothing to disclose.

*Relationship Disclosure
+ Unlabeled Use of Products/Investigational Use Disclosure